澳大利亚基于家族史的结直肠癌筛查建模研究数据集

数据集获取（Figshare）

• 源站标题：Family history–based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios
• DOI：10.1371/journal.pmed.1002630
• 发布日期：2018-08-16
• 文件数：16 个
• 文件总体积：1.99 MB
• 源站页面：https://plos.figshare.com/articles/dataset/Family_history_based_colorectal_cancer_screening_in_Australia_A_modelling_study_of_the_costs_benefits_and_harms_of_different_participation_scenarios/6974933

命令行下载

curl -L -o "pmed.1002630.s001.docx" "https://ndownloader.figshare.com/files/12795365"
curl -L -o "pmed.1002630.s002.tif" "https://ndownloader.figshare.com/files/12795368"
curl -L -o "pmed.1002630.s003.tif" "https://ndownloader.figshare.com/files/12795371"
curl -L -o "pmed.1002630.s004.tif" "https://ndownloader.figshare.com/files/12795374"
curl -L -o "pmed.1002630.s005.tif" "https://ndownloader.figshare.com/files/12795377"
curl -L -o "pmed.1002630.s006.tif" "https://ndownloader.figshare.com/files/12795380"
curl -L -o "pmed.1002630.s007.tif" "https://ndownloader.figshare.com/files/12795383"
curl -L -o "pmed.1002630.s008.tif" "https://ndownloader.figshare.com/files/12795386"

文件清单

• pmed.1002630.s001.docx（15.76 KB）
• pmed.1002630.s002.tif（396.22 KB）
• pmed.1002630.s003.tif（267.03 KB）
• pmed.1002630.s004.tif（266.66 KB）
• pmed.1002630.s005.tif（271.61 KB）
• pmed.1002630.s006.tif（221.67 KB）
• pmed.1002630.s007.tif（222.28 KB）
• pmed.1002630.s008.tif（220.32 KB）
• pmed.1002630.s009.docx（19.16 KB）
• pmed.1002630.s010.docx（12.52 KB）
• pmed.1002630.s011.docx（12.57 KB）
• pmed.1002630.s012.docx（12.46 KB）
• pmed.1002630.s013.docx（11.80 KB）
• pmed.1002630.s014.docx（13.90 KB）
• pmed.1002630.s015.docx（13.46 KB）
• pmed.1002630.s016.docx（12.32 KB）

文件总体积 1.99 MB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
The Australian National Bowel Cancer Screening Programme (NBCSP) was introduced in 2006. When fully implemented, the programme will invite people aged 50 to 74 to complete an immunochemical faecal occult blood test (iFOBT) every 2 years.
Methods and findings
To investigate colorectal cancer (CRC) screening occurring outside of the NBCSP, we classified participants (n = 2,480) in the Australasian Colorectal Cancer Family Registry (ACCFR) into 3 risk categories (average, moderately increased, and potentially high) based on CRC family history and assessed their screening practices according to national guidelines. We developed a microsimulation to compare hypothetical screening scenarios (70% and 100% uptake) to current participation levels (baseline) and evaluated clinical outcomes and cost for each risk category. The 2 main limitations of this study are as follows: first, the fact that our cost-effectiveness analysis was performed from a third-party payer perspective, which does not include indirect costs and results in overestimated cost-effectiveness ratios, and second, that our natural history model of CRC does not include polyp sojourn time, which determines the rate of cancerous transformation.
Screening uptake was low across all family history risk categories (64%–56% reported no screening). For participants at average risk, 18% reported overscreening, while 37% of those in the highest risk categories screened according to guidelines. Higher screening levels would substantially reduce CRC mortality across all risk categories (95 to 305 fewer deaths per 100,000 persons in the 70% scenario versus baseline). For those at average risk, a fully implemented NBCSP represented the most cost-effective approach to prevent CRC deaths (AUS$13,000–16,000 per quality-adjusted life year [QALY]). For those at moderately increased risk, higher adherence to recommended screening was also highly cost-effective (AUS$19,000–24,000 per QALY).
Conclusion
Investing in public health strategies to increase adherence to appropriate CRC screening will save lives and deliver high value for money.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pmed.1002630（source: https://plos.figshare.com/articles/dataset/Family_history_based_colorectal_cancer_screening_in_Australia_A_modelling_study_of_the_costs_benefits_and_harms_of_different_participation_scenarios/6974933）。